O13.1 - ORAL ZOLIFLODACIN FOR TREATMENT OF UNCOMPLICATED GONORRHEA: SUBGROUP ANALYSES BY RACE AND REGION OF A GLOBAL PHASE 3 RANDOMIZED CONTROLLED CLINICAL TRIAL
O13.3 - GEPOTIDACIN AND CEFTRIAXONE/AZITHROMYCIN EFFICACY BY BASELINE PHENOTYPES AND GENOTYPES OF NEISSERIA GONORRHOEAE RECOVERED FROM A CLINICAL TRIAL FOR UNCOMPLICATED UROGENITAL GONORRHEA (EAGLE-1)
O14.4 - EVALUATING THE PERFORMANCE OF THE SYPHILIS HEALTH CHECK RAPID TEST AS A SCREENING TOOL FOR PEOPLE WHO INJECT DRUGS (PWID), ENCOUNTERED IN NON-CLINICAL SETTINGS IN LOS ANGELES COUNTY (LAC), 2022
O15.4 - INCREASING PREVALENCE OF TETRACYCLINE RESISTANT GONORRHEA AMONG SEXUALLY TRANSMITTED INFECTION (STI) CLINIC PATIENTS IS CORRELATED WITH INCREASING USE OF DOXYCYCLINE FOR TREATMENT AND POST-EXPOSURE PROPHYLAXIS (DOXY-PEP), SAN FRANCISCO, 2002-2023
Location: Salon West
Presenter and Primary Author: Robert P. Kohn, MPH – San Francisco Department of Public Health
8:00 AM – 9:15 AM EST
O15.5 - IMPACT OF PREGNANCY ON THE ASSOCIATION BETWEEN METHAMPHETAMINE USE AND SYPHILIS TREATMENT IN LOS ANGELES COUNTY
S12.6 - THE REVERSE SEQUENCE ALGORITHM IS LESS COST-EFFECTIVE THAN THE TRADITIONAL ALGORITHM AT SCREENING FOR SYPHILIS AMONG GAY, BISEXUAL, AND OTHER MEN WHO HAVE SEX WITH MEN AND PREVENTING CONGENITAL SYPHILIS AMONG PREGNANT PEOPLE
O16.4 - IN VITRO ACTIVITY OF GEPOTIDACIN AGAINST BASELINE NEISSERIA GONORRHOEAE PHENOTYPES AND GENOTYPES RECOVERED FROM A CLINICAL TRIAL FOR UNCOMPLICATED UROGENITAL GONORRHEA (EAGLE-1)
O16.5 - EXPANDED SURRG CASE INVESTIGATION OUTCOMES AMONG PATIENTS DIAGNOSED WITH GONORRHEA WITH REDUCED ANTIMICROBIAL SUSCEPTIBILITY IN NEW YORK CITY, 2017-2021
Moderator: John R. Papp, PhD – Centers for Disease Control and Prevention
9:30 AM – 10:45 AM EST
O17.1 - RECENT DOXY-PEP USE, TETRACYCLINE-RESISTANT STAPHYLOCOCCUS AUREUS, AND GROUP A STREPTOCOCCUS CARRIAGE AMONG SEXUAL HEALTH CLINIC PATIENTS IN SEATTLE, WASHINGTON
O17.5 - DOXYCYCLINE POST-EXPOSURE PROPHYLAXIS (DOXY-PEP) IS ASSOCIATED WITH DECLINES IN CITYWIDE CHLAMYDIA IN MSM AND TRANSGENDER WOMEN IN SAN FRANCISCO, AND DECLINES WERE SIMILAR FOR WHITE AND LATINX POPULATIONS
O18.1 - RACISM AND DISCRIMINATION IMPACTS SEXUAL HEALTH OF BLACK ADOLESCENT
Location: 212-213-214
Presenter and Primary Author: Ashley V. Hill, DrPH, MPH (she/her/hers) – University of Illinois Chicago School of Public Health/ Center of Excellence in Maternal and Child Health
9:30 AM – 10:45 AM EST
O18.2 - RAPID ETHNOGRAPHIC ASSESSMENT OF GENERAL AND SEXUAL HEALTH-SEEKING BEHAVIORS AMONG YOUNG BLACK WOMEN IN DETROIT
Location: 212-213-214
Presenter and Co-Author: Jill C. Diesel, PhD, MPH (she/her/hers) – Centers for Disease Control and Prevention / Michigan Department of Health and Human Services
9:30 AM – 10:45 AM EST
O18.3 - CHLAMYDIA PRESCRIBING PRACTICES AFTER CHANGES TO NATIONAL TREATMENT GUIDELINES, UNITED STATES (US) 2016 – 2022
O18.4 - (WITHDRAWN) ASIAN AMERICAN YOUNG ADULT WOMEN'S EXPERIENCE TALKING WITH MOTHERS ABOUT SEXUAL HEALTH IN THE UNITED STATES
Location: 212-213-214
9:30 AM – 10:45 AM EST
O18.5 - BIOLOGIC FALSE POSITIVE SYPHILIS RESULTS AMONG UNACCOMPANIED CHILDREN IN THE CARE OF THE U.S. OFFICE OF REFUGEE RESETTLEMENT — UNITED STATES, 2023
Location: 212-213-214
Presenter and Primary Author: Kelly Garcia-Eberhardt, MPH (she/her/hers) – Office of Refugee Resettlement, Administration for Children & Families, U.S. Health and Human Services
9:30 AM – 10:45 AM EST
O18.6 - (WITHDRAWN) ACCESS TO GENDER-AFFIRMING HORMONE THERAPY FACILITATES UPTAKE IN STI PREVENTION: AN EXPLORATORY STUDY
.png)